Indrayani Biotech Ltd announced on April 3, 2025, an amendment to their rights issue, issuing partly paid-up shares for a total of Rs 49.90 Crores instead of fully paid-up shares, with the board's prior meeting approval on November 14, 2024, also announcing resignation of CFO Vinayaka Bodala effective the same date.